Sodium valproate: core anti-epilepsy drug and application analysis

First paragraph: Summary of content
Sodium valproate is a broad-spectrum anti-epileptic drug mainly used to treat epilepsy, bipolar disorder and migraine. Its core mechanism is to enhance GABAergic nerve conduction and inhibit abnormal neuron discharge. This article starts from four parts: pharmacological effects, clinical applications, precautions and manufacturers, focusing on explaining the balance between its efficacy and safety, and secondly analyzing the characteristics of different dosage forms. The structure follows the logical progression of "mechanism-indication-risk-product" to help readers systematically understand the drug.

Paragraph 2: Pharmacological mechanism and indications
Sodium valproate increases the level of inhibitory neurotransmitters in the brain by inhibiting voltage-dependent sodium channels and GABA transaminase. Clinical data shows that its effectiveness in treating generalized tonic-clonic seizures can reach 75% (International League Against Epilepsy 2022 Annual Report). In addition to epilepsy, the FDA has approved it for the maintenance treatment of the manic phase of bipolar disorder, and China's "Guidelines for the Prevention and Treatment of Migraine" also recommends it as a preventive medication. It is worth noting that sustained-release tablets can reduce blood concentration fluctuations and reduce the incidence of gastrointestinal reactions by about 30%.

Paragraph 3: Precautions for use
Liver function needs to be monitored regularly during medication (once every 3 months for the first 6 months) and blood drug concentration (therapeutic window 50-100 μg/ml). It is contraindicated in pregnant women because the risk of teratogenesis is as high as 10% (American Academy of Neurology warning). Common adverse reactions include tremor, hair loss, and weight gain, which are positively related to dose. The Journal of Clinical Neuropharmacology in 2019 pointed out that combined use with lamotrigine may increase the risk of rash, and the dose needs to be gradually adjusted.

Paragraph 4: Dosage Form and Production Information
The mainstream dosage forms in China include ordinary tablets, sustained-release tablets and syrups. The bioavailability of products from different manufacturers varies by 5%-8%. The main manufacturers and products are as follows:

Paragraph 5: Summary and Outlook
As a classic antiepileptic drug, sodium valproate still occupies an important position in the neuropsychiatric field. With the development of precision medicine, genetic testing (such as POLG genetic screening) will further improve drug safety. It is recommended that patients choose the appropriate dosage form based on their individual circumstances under the guidance of a doctor, and adhere to therapeutic drug monitoring to achieve the best efficacy-risk ratio.

Quote sources:
1. International League Against Epilepsy "Guidelines for the Treatment of Epilepsy (2022 Edition)"
2. US FDA Drug Insert (NDA 018723)
3. Chinese Medical Association's "Clinical Diagnosis and Treatment Guidelines: Epilepsy Volume"
4. Sanofi Pharmaceutical Co., Ltd. Product Manual